Early Pancreatic Cancer: Clinical Implications, Workup, and Imaging Findings with Histopathologic Correlation for Personalized Surveillance

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related mortality, largely because most cases are diagnosed at an advanced, unresectable stage. Early detection is the most effective strategy for improving patient outcomes, yet there is no standard population-based screening program. Current efforts focus on high-risk populations, utilizing a combination of MRI and endoscopic ultrasound (EUS) to identify precursor lesions and small, localized carcinomas.

For clinical and research purposes, early pancreatic cancer is defined as precursor lesions with high-grade dysplasia or invasive carcinomas 2.0 cm or smaller that remain confined to the pancreas. The progression from low-grade precursor lesions to invasive cancer is a multi-year process driven by the accumulation of genetic mutations. While stage 0 and stage I cancers offer a significant window for curative intervention, their aggressive biological nature means that even small tumors can progress rapidly, making timely identification critical.

Radiologists must look beyond the search for a visible mass. Because early-stage lesions are often microscopic, they frequently manifest through indirect changes in the surrounding pancreatic tissue. Key indicators include:

• Focal Pancreatic Parenchymal Atrophy (FPPA): Localized loss of acinar structure and fibrosis, often caused by the inflammatory response to precursor lesions.
• Ductal Abnormalities: Localized stenosis of the main pancreatic duct (MPD) or upstream dilatation, which can serve as a sentinel sign of an underlying, non-visible lesion.
• Enhancement Patterns: Subtle hyperattenuation on delayed-phase CT or hyperintensity on diffusion-weighted MRI, which may reflect the desmoplastic stroma associated with early malignancy.

These indirect findings often precede the detection of a solid mass by 1–5 years. When these signs are identified, they provide a vital opportunity for intervention, even in the absence of a clearly defined tumor on initial imaging.